KMT2A/C mutations function as a potential predictive biomarker for immunotherapy in solid tumors

by Rui Zhang, Hao-Xiang Wu, Ming Xu, Xiaoyan Xie
Published 2020-12-01

Advancing to the era of cancer immunotherapy

by Yun Wang, Min Wang, Hao‐Xiang Wu, Rui‐Hua Xu
Published 2021-09-01

Designing gene panels for tumor mutational burden estimation: the need to shift from ‘correlation’ to ‘accuracy’

by Hao-Xiang Wu, Zi-Xian Wang, Qi Zhao, Feng Wang, Rui-Hua Xu
Published 2019-08-01

EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers

by Zhen Zhang, Hao-Xiang Wu, Wu-Hao Lin, Zi-Xian Wang, Lu-Ping Yang, Zhao-Lei Zeng, Hui-Yan Luo
Published 2021-02-01

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers

by Hao-Xiang Wu, Yan-Xing Chen, Zi-Xian Wang, Qi Zhao, Ming-Ming He, Ying-Nan Wang, Feng Wang, Rui-Hua Xu
Published 2019-10-01

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer

by Gong Chen, Junjie Peng, Qian Xiao, Hao-Xiang Wu, Xiaojun Wu, Fulong Wang, Liren Li, Peirong Ding, Qi Zhao, Yaqi Li, Da Wang, Yang Shao, Hua Bao, Zhizhong Pan, Ke-Feng Ding, Sanjun Cai, Feng Wang, Rui-Hua Xu
Published 2021-05-01

Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review

by Zi-yun Qiao, Zi-jie Zhang, Zi-cheng Lv, Huan Tong, Zhi-feng Xi, Hao-xiang Wu, Xiao-song Chen, Xiao-song Chen, Lei Xia, Lei Xia, Hao Feng, Hao Feng, Hao Feng, Jian-jun Zhang, Qiang Xia, Qiang Xia, Qiang Xia
Published 2021-07-01